http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Veradigm Reveals New Insights on the Prevalence of Cardiovascular Conditions in the U.S.
-
Veradigm and American College of Cardiology Launch Influenza Vaccination Education Initiative to Improve Cardiovascular Health
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors with to Secure Counsel Before Important January 22 Deadline in Securities Class Action �
-
New Veradigm Leadership Provides Outlook on Business and Strategy, and Refreshed Financial Estimates for Fiscal 2023
-
Veradigm Selects MedAllies as its Qualified Health Information Network™ (QHIN™ ) Partner
-
Veradigm Leadership Team to Present at J.P. Morgan Healthcare Conference
-
Veradigm (MDRX) Acquires Koha Health
-
Veradigm Strengthens Award-Winning Revenue Cycle Services Portfolio with Acquisition of Full-Service RCM Company
-
ROSEN, A LONGSTANDING LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MDRX
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MDR
-
Veradigm (MDRX) Announces that Nasdaq Hearings Panel has Granted its Continued Listing
-
Veradigm Inc. Announces that Nasdaq Hearings Panel has Granted its Continued Listing, Pending Return to Compliance with Nasdaq Filing Requirements
-
Veradigm to Enhance Independent Practice Financial Management with AI for Practice Fusion Billing Services
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MDRX
-
Veradigm (MDRX) Announces Greg Garrison Named Executive Chairman; Dr. Shih-Yin Ho Appointed Interim CEO; Lee Westerfield Appointed Interim CFO
-
Veradigm Inc. Announces Leadership Transition
-
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities C
-
Veradigm (MDRX) Receives Nasdaq Notice Regarding Delayed Form 10-Q
-
Veradigm Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q
-
Veradigm to Simplify Patient Payment Journey with Veradigm Intelligent Payments
-
Veradigm (MDRX) Announces Receipt of Nasdaq Stay Extension
-
Veradigm Inc. Announces Receipt of Nasdaq Stay Extension
-
Veradigm Joins FDB Vela ePrescribing Network to Offer Prescribers & Patients Greater Choice, Cost Transparency
-
Holmusk, Veradigm Announce New Phase of Strategic Investment to Fuel Innovation and Close the Evidence Gap in Behavioral Health
-
Veradigm and On Belay Health Solutions Collaborate to Expand Value-Based Care Solutions to More Primary Care Practices
-
Veradigm (MDRX) Announces Receipt of Nasdaq Delisting Notice and Intent to Appeal
-
Veradigm Inc. Announces Receipt of Nasdaq Delisting Notice and Intent to Appeal
-
Veradigm Inc. Provides Audit Update and Updates Financial Guidance for 2023
-
Veradigm Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing
-
Veradigm Announces New and Expanded Provider Partnerships
-
Veradigm (MDRX) Increases Presence in Payer Market
-
Veradigm Increasing Presence in Payer Market
-
Veradigm (MDRX) Receives Nasdaq Approval of Plan to Regain Listing Compliance
-
Veradigm Inc. Receives Approval from Nasdaq of Plan to Regain Listing Compliance
-
Veradigm Payerpath™ Rated #1 End-to-End Revenue Cycle Management (RCM) Software
-
Veradigm (MDRX) Receives Nasdaq Non-compliance Notice
-
Veradigm Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q Filing
-
Veradigm Network Solution Practice Fusion EHR Receives Top Ranking
-
Veradigm (MDRX) Receives Nasdaq Notice Regarding Delayed Form 10-K Filing, Provides Update on 4th Quarter and Full Fiscal Year 2022 Reporting of Results
-
Veradigm Inc. Receives Nasdaq Notice Regarding Delayed Form 10-K Filing, Provides Update on 4th Quarter and Full Fiscal Year 2022 Reporting of Results
-
Veradigm Practice Management Ranks First in Practice Management Solutions from Black Book™ Research
-
Veradigm Inc. Update on 4th Quarter and Full Fiscal Year 2022 Reporting of Results
-
Veradigm Announces Two New Appointments to Its Board
-
Veradigm to Release Fourth Quarter and Fiscal Year 2022 Financial Results March 1
-
Veradigm and HealthVerity Collaborate to Advance Real-World Evidence and Care for Patients with Cardiovascular Disease and Diabetes
-
Veradigm FollowMyHealth Named Most Improved Software Product by KLAS
-
Veradigm® Network EHR Data is Now Available in the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) Format
-
Veradigm (MDRX) Announces $250M Share Buyback, Guides FY23
-
Veradigm Announces New Share Repurchase Program and Initial Financial Guidance for Fiscal 2023
-
Veradigm (MDRX) Reports Q4 Results

